Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.
| Title: | Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment. |
|---|---|
| Authors: | von Haehling S; Department of Cardiology and Pneumology, University of Göttingen Medical Center, Robert-Koch-Strasse 40, 37075, Göttingen, Germany. stephan.von.haehling@web.de.; German Center for Cardiovascular Research (DZHK), Partner Site Göttingen, Göttingen, Germany. stephan.von.haehling@web.de.; Assmus B; Department of Cardiology and Angiology, Universitätsklinikum Gießen und Marburg, Giessen, Germany.; Bekfani T; Department of Cardiology and Angiology, Universitätsklinikum Magdeburg, Magdeburg, Germany.; Dworatzek E; Institute of Gender in Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Edelmann F; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.; Department of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charité - Medical Heart Center of Charité and German Heart Institute Berlin, Campus Virchow-Klinikum, Berlin, Germany.; DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany.; Hashemi D; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.; Department of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charité - Medical Heart Center of Charité and German Heart Institute Berlin, Campus Virchow-Klinikum, Berlin, Germany.; DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany.; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité Digital Clinician Scientist Program, Berlin, Germany.; Hellenkamp K; Department of Cardiology and Pneumology, University of Göttingen Medical Center, Robert-Koch-Strasse 40, 37075, Göttingen, Germany.; Kempf T; Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.; Raake P; I. Medical Department, Cardiology, Pneumology, Endocrinology and Intensive Care Medicine, University Hospital Augsburg, University of Augsburg, Augsburg, Germany.; Schütt KA; Department of Internal Medicine I, University Hospital RWTH Aachen, Aachen, Germany.; Wachter R; Department of Cardiology and Pneumology, University of Göttingen Medical Center, Robert-Koch-Strasse 40, 37075, Göttingen, Germany.; German Center for Cardiovascular Research (DZHK), Partner Site Göttingen, Göttingen, Germany.; Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, Leipzig, Germany.; Schulze PC; Department of Internal Medicine I, Division of Cardiology, University Hospital Jena, FSU, Jena, Germany.; Hasenfuss G; Department of Cardiology and Pneumology, University of Göttingen Medical Center, Robert-Koch-Strasse 40, 37075, Göttingen, Germany.; German Center for Cardiovascular Research (DZHK), Partner Site Göttingen, Göttingen, Germany.; Böhm M; Kardiologie, Angiologie und Internistische Intensivmedizin, Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes, Saarland University, Homburg, Germany.; Bauersachs J; Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany. |
| Source: | Clinical research in cardiology : official journal of the German Cardiac Society [Clin Res Cardiol] 2024 Sep; Vol. 113 (9), pp. 1287-1305. Date of Electronic Publication: 2024 Apr 11. |
| Publication Type: | Journal Article; Review |
| Language: | English |
| Journal Info: | Publisher: Springer Medizin Country of Publication: Germany NLM ID: 101264123 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1861-0692 (Electronic) Linking ISSN: 18610684 NLM ISO Abbreviation: Clin Res Cardiol Subsets: MEDLINE |
| Imprint Name(s): | Publication: Aug. 2007- : Heidelberg, Germany : Springer Medizin; Original Publication: Darmstadt, Germany : Springer Medizin, [2006]- |
| MeSH Terms: | Heart Failure*/diagnosis ; Heart Failure*/physiopathology ; Stroke Volume*/physiology; Ventricular Function, Left/physiology ; Humans ; Risk Assessment |
| Abstract: | The aetiology of heart failure with preserved ejection fraction (HFpEF) is heterogenous and overlaps with that of several comorbidities like atrial fibrillation, diabetes mellitus, chronic kidney disease, valvular heart disease, iron deficiency, or sarcopenia. The diagnosis of HFpEF involves evaluating cardiac dysfunction through imaging techniques and assessing increased left ventricular filling pressure, which can be measured directly or estimated through various proxies including natriuretic peptides. To better narrow down the differential diagnosis of HFpEF, European and American heart failure guidelines advocate the use of different algorithms including comorbidities that require diagnosis and rigorous treatment during the evaluation process. Therapeutic recommendations differ between guidelines. Whilst sodium glucose transporter 2 inhibitors have a solid evidence base, the recommendations differ with regard to the use of inhibitors of the renin-angiotensin-aldosterone axis. Unless indicated for specific comorbidities, the use of beta-blockers should be discouraged in HFpEF. The aim of this article is to provide an overview of the current state of the art in HFpEF diagnosis, clinical evaluation, and treatment.; (© 2024. The Author(s).) |
| References: | Circ Heart Fail. 2016 Sep;9(9):. (PMID: 27609832); Front Cardiovasc Med. 2020 Oct 14;7:581211. (PMID: 33173788); Eur Heart J. 2022 May 21;43(20):1941-1951. (PMID: 35139159); Circulation. 2016 Feb 2;133(5):484-92. (PMID: 26746177); Circulation. 2016 Feb 23;133(8):706-16. (PMID: 26819374); Front Cardiovasc Med. 2022 Jul 22;9:866131. (PMID: 35935619); Eur J Heart Fail. 2023 Jul;25(7):936-955. (PMID: 37461163); Am J Cardiol. 2012 Sep 15;110(6):870-6. (PMID: 22681864); Circulation. 2021 Apr 13;143(15):1484-1498. (PMID: 33472397); Circulation. 2022 May 3;145(18):e895-e1032. (PMID: 35363499); Eur J Heart Fail. 2022 Aug;24(8):1327-1345. (PMID: 35775383); JACC Cardiovasc Imaging. 2019 Mar;12(3):433-442. (PMID: 30121261); Eur Heart J. 2014 Feb;35(7):455-69. (PMID: 24164864); Sci Rep. 2021 Jun 2;11(1):11648. (PMID: 34078942); Diabetes Care. 2004 Mar;27(3):699-703. (PMID: 14988288); Eur J Prev Cardiol. 2021 Aug 9;28(9):1022-1029. (PMID: 33624112); J Am Coll Cardiol. 2018 Feb 20;71(7):782-793. (PMID: 29447741); Diabetes Care. 2015 Sep;38(9):1730-5. (PMID: 26180105); J Am Soc Echocardiogr. 2016 Apr;29(4):277-314. (PMID: 27037982); N Engl J Med. 2020 Oct 8;383(15):1436-1446. (PMID: 32970396); Circulation. 2021 Jan 26;143(4):310-321. (PMID: 33095032); J Card Fail. 2023 Mar;29(3):375-388. (PMID: 37162126); Eur J Heart Fail. 2018 Apr;20(4):715-722. (PMID: 28949052); Circulation. 2002 Mar 19;105(11):1387-93. (PMID: 11901053); J Am Coll Cardiol. 2003 Jun 4;41(11):2010-7. (PMID: 12798574); Circ Heart Fail. 2014 Jul;7(4):590-5. (PMID: 24874200); Clin Cardiol. 2023 Mar;46(3):260-268. (PMID: 36644878); J Am Coll Cardiol. 2022 Nov 1;80(18):1705-1717. (PMID: 36041668); Circulation. 2019 Jul 16;140(3):196-206. (PMID: 31117814); Eur J Heart Fail. 2018 Aug;20(8):1230-1239. (PMID: 29431256); Proc Nutr Soc. 2015 Nov;74(4):367-77. (PMID: 26264581); Circulation. 2023 May 30;147(22):1654-1669. (PMID: 37070436); Br J Pharmacol. 2022 Jul;179(13):3119-3134. (PMID: 34643952); ESC Heart Fail. 2022 Feb;9(1):133-145. (PMID: 34964300); Eur J Heart Fail. 2016 Dec;18(12):1411-1414. (PMID: 27612005); JACC Heart Fail. 2018 Oct;6(10):859-870. (PMID: 30098962); JACC CardioOncol. 2022 Nov 15;4(4):427-441. (PMID: 36444232); N Engl J Med. 2020 Oct 8;383(15):1413-1424. (PMID: 32865377); J Am Heart Assoc. 2020 Dec 15;9(24):e015752. (PMID: 33289458); Eur Heart J. 2016 Feb 1;37(5):455-62. (PMID: 26374849); Eur J Heart Fail. 2023 May;25(5):669-672. (PMID: 37013269); Int J Cardiol. 2020 Dec 1;320:49-54. (PMID: 32682962); J Am Coll Cardiol. 2017 Sep 26;70(13):1618-1636. (PMID: 28935040); Expert Opin Pharmacother. 2022 Apr;23(6):673-680. (PMID: 35260016); Front Cardiovasc Med. 2022 Mar 10;9:829512. (PMID: 35360025); Open Heart. 2019 Apr 3;6(1):e001012. (PMID: 31168385); J Am Coll Cardiol. 2022 Oct 4;80(14):1302-1310. (PMID: 36041912); J Am Soc Echocardiogr. 2020 Oct;33(10):1163-1171. (PMID: 33010852); JACC Cardiovasc Imaging. 2010 Feb;3(2):155-64. (PMID: 20159642); Nat Rev Cardiol. 2017 Jun;14(6):323-341. (PMID: 28436486); Eur J Heart Fail. 2020 Dec;22(12):2314-2326. (PMID: 32949422); Circ Res. 2017 Apr 14;120(8):1243-1245. (PMID: 28408453); Nat Med. 2022 Mar;28(3):568-574. (PMID: 35228754); JAMA Cardiol. 2022 Sep 1;7(9):891-899. (PMID: 35830183); Eur Heart J. 2008 Jun;29(11):1377-85. (PMID: 18413309); Eur Heart J. 2005 Feb;26(3):215-25. (PMID: 15642700); N Engl J Med. 2019 Oct 24;381(17):1609-1620. (PMID: 31475794); Circulation. 2021 Jan 26;143(4):337-349. (PMID: 33175585); PLoS One. 2017 Feb 15;12(2):e0171542. (PMID: 28199339); Eur J Heart Fail. 2020 Jul;22(7):1065-1075. (PMID: 32654354); JAMA. 1979 May 11;241(19):2035-8. (PMID: 430798); JAMA Cardiol. 2022 Dec 1;7(12):1259-1263. (PMID: 36190011); JAMA. 2014 Nov 19;312(19):2008-18. (PMID: 25399276); Int J Cardiol. 2016 Nov 1;222:41-46. (PMID: 27454614); Eur J Heart Fail. 2023 May;25(5):714-723. (PMID: 36781201); Diabetologia. 2012 Aug;55(8):2154-62. (PMID: 22618812); ESC Heart Fail. 2022 Apr;9(2):874-884. (PMID: 35170249); Lancet. 2022 Mar 19;399(10330):1130-1140. (PMID: 35120593); Eur J Heart Fail. 2020 Apr;22(4):713-722. (PMID: 31912605); Eur J Heart Fail. 2019 Nov;21(11):1299-1305. (PMID: 31646718); Curr Cardiol Rep. 2020 Jul 30;22(9):99. (PMID: 32728829); JACC Basic Transl Sci. 2022 Dec 21;8(2):141-151. (PMID: 36908662); N Engl J Med. 2023 Jan 12;388(2):117-127. (PMID: 36331190); Circ Heart Fail. 2017 Jan;10(1):. (PMID: 28062538); Circulation. 2015 Jan 6;131(1):34-42. (PMID: 25406305); Eur Heart J. 2006 Oct;27(19):2338-45. (PMID: 16963472); Circulation. 2022 Jul 26;146(4):289-298. (PMID: 35766022); Eur Heart J. 2023 Aug 14;44(31):2947-2962. (PMID: 37217188); ESC Heart Fail. 2021 Apr;8(2):1304-1313. (PMID: 33522131); Arch Cardiovasc Dis. 2018 Jan;111(1):5-16. (PMID: 28943262); Eur J Heart Fail. 2020 Oct;22(10):1817-1825. (PMID: 32741057); Circulation. 2022 Aug 16;146(7):506-518. (PMID: 35862208); Nat Rev Cardiol. 2015 Nov;12(11):659-69. (PMID: 26194551); JAMA Cardiol. 2023 Jan 1;8(1):56-65. (PMID: 36326604); Circulation. 2021 Oct 19;144(16):1284-1294. (PMID: 34459213); Circulation. 2021 Apr 6;143(14):1377-1390. (PMID: 33554614); Lancet. 2020 Sep 19;396(10254):819-829. (PMID: 32877652); Circulation. 2023 Jan 17;147(3):201-211. (PMID: 36335479); Eur J Heart Fail. 2018 Apr;20(4):738-747. (PMID: 29251818); Hypertension. 2015 Feb;65(2):257-63. (PMID: 25368026); Eur J Heart Fail. 2019 Jun;21(6):715-731. (PMID: 31222929); Eur Heart J. 2023 May 1;44(17):1544-1556. (PMID: 36924194); Circulation. 2023 Jun 20;147(25):1872-1886. (PMID: 37154040); Eur J Heart Fail. 2017 Dec;19(12):1606-1614. (PMID: 28371075); Eur Heart J. 2015 Jul 14;36(27):1718-27, 1727a-1727c. (PMID: 25888006); Eur J Heart Fail. 2016 Jun;18(6):613-25. (PMID: 27324686); Eur Heart J. 2023 Aug 14;44(31):2994-2997. (PMID: 37403607); JACC Cardiovasc Imaging. 2022 Nov;15(11):1870-1882. (PMID: 36357130); Eur Heart J. 2014 Nov 21;35(44):3103-12. (PMID: 25161181); Eur Heart J. 2022 Nov 1;43(41):4362-4373. (PMID: 35900838); Eur J Heart Fail. 2015 Oct;17(10):1050-6. (PMID: 26011677); Nat Rev Cardiol. 2022 May;19(5):302-313. (PMID: 34992256); Am J Physiol Heart Circ Physiol. 2018 May 1;314(5):H1033-H1042. (PMID: 29424571); Eur J Heart Fail. 2023 Aug;25(8):1337-1348. (PMID: 37062851); Eur Heart J. 2018 Oct 14;39(39):3584-3592. (PMID: 30060125); Eur J Heart Fail. 2017 Jan;19(1):54-65. (PMID: 27790816); Eur J Heart Fail. 2017 Dec;19(12):1574-1585. (PMID: 28386917); N Engl J Med. 2021 Jan 14;384(2):117-128. (PMID: 33200892); N Engl J Med. 2021 Oct 14;385(16):1451-1461. (PMID: 34449189); Eur Heart J. 2021 Sep 21;42(36):3599-3726. (PMID: 34447992); Diabetes Care. 2004 Aug;27(8):1879-84. (PMID: 15277411); N Engl J Med. 2023 May 18;388(20):1833-1842. (PMID: 36876753); Pharmacol Ther. 2023 Mar;243:108356. (PMID: 36750166); Diabetes Care. 2001 Sep;24(9):1614-9. (PMID: 11522708); ESC Heart Fail. 2023 Aug;10(4):2588-2595. (PMID: 37321596); JACC Cardiovasc Interv. 2019 Jan 28;12(2):155-165. (PMID: 30594510); N Engl J Med. 2020 Mar 5;382(10):973. (PMID: 32130823); Diabetes Care. 2010 Sep;33(9):2084-9. (PMID: 20805280); Curr Cardiol Rep. 2017 Aug;19(8):65. (PMID: 28639223); N Engl J Med. 2008 Dec 4;359(23):2456-67. (PMID: 19001508); N Engl J Med. 2014 Sep 11;371(11):993-1004. (PMID: 25176015); J Cachexia Sarcopenia Muscle. 2020 Oct;11(5):1242-1249. (PMID: 32767518); Eur J Heart Fail. 2021 Jan;23(1):92-113. (PMID: 32392403); Eur Heart J. 2023 Aug 14;44(31):2982-2993. (PMID: 37210743); Diabetes Care. 2017 May;40(5):671-678. (PMID: 28255009); Lancet. 2003 Sep 6;362(9386):777-81. (PMID: 13678871); Cardiovasc Diabetol. 2019 Oct 4;18(1):129. (PMID: 31585532); Curr Treat Options Cardiovasc Med. 2018 Sep 27;20(11):90. (PMID: 30259312); Eur J Heart Fail. 2023 Jan;25(1):63-73. (PMID: 36343200); ESC Heart Fail. 2022 Dec;9(6):4120-4128. (PMID: 36070881); ESC Heart Fail. 2023 Jun;10(3):1531-1544. (PMID: 36460629); N Engl J Med. 2022 Sep 22;387(12):1089-1098. (PMID: 36027570); Circulation. 2020 Feb 4;141(5):338-351. (PMID: 31736337); Eur Heart J. 2023 Oct 1;44(37):3627-3639. (PMID: 37622666); J Am Coll Cardiol. 2023 Jun 6;81(22):2131-2144. (PMID: 37257948); Heart. 2017 Feb;103(3):184-189. (PMID: 27940967); Circ Heart Fail. 2010 Sep;3(5):588-95. (PMID: 20543134); Eur J Heart Fail. 2023 May;25(5):657-668. (PMID: 36994635); Circulation. 2018 Jul 3;138(1):7-9. (PMID: 29967228); Circ Heart Fail. 2015 May;8(3):448-54. (PMID: 25759458); ESC Heart Fail. 2021 Dec;8(6):5010-5021. (PMID: 34498430); J Am Coll Cardiol. 2012 Jul 24;60(4):277-82. (PMID: 22813603); J Am Coll Cardiol. 2013 Jul 23;62(4):263-71. (PMID: 23684677); Eur Heart J. 2019 Oct 21;40(40):3297-3317. (PMID: 31504452); Curr Heart Fail Rep. 2023 Feb;20(1):76-87. (PMID: 36802007); JAMA Netw Open. 2019 Dec 2;2(12):e1916598. (PMID: 31800067); Circulation. 2018 Aug 28;138(9):861-870. (PMID: 29792299); JACC CardioOncol. 2021 Oct 19;3(4):488-505. (PMID: 34729521); Circ Cardiovasc Imaging. 2016 Mar;9(3):. (PMID: 26941415); Circulation. 2022 May 24;145(21):1592-1604. (PMID: 35354306) |
| Contributed Indexing: | Keywords: Diagnosis; Diastolic; Heart failure; Preserved ejection fraction; Treatment |
| Entry Date(s): | Date Created: 20240411 Date Completed: 20240903 Latest Revision: 20240906 |
| Update Code: | 20260130 |
| PubMed Central ID: | PMC11371894 |
| DOI: | 10.1007/s00392-024-02396-4 |
| PMID: | 38602566 |
| Database: | MEDLINE |
Journal Article; Review